(Q34420107)

2 August 2017

title

Fermentable oligosaccharides, disaccharides, monosaccharides and polyols: role in irritable bowel syndrome (English)

1 reference

2 August 2017

1 reference

1 reference

irritable bowel syndrome

1 reference

Caroline J Tuck

1

1 reference

2 August 2017

Jane G Muir

series ordinal

2

1 reference

2 August 2017

Jacqueline S Barrett

series ordinal

3

1 reference

2 August 2017

Peter R Gibson

series ordinal

4

1 reference

2 August 2017

publication date

15 May 2014

1 reference

Expert Review of Gastroenterology & Hepatology

2 August 2017

published in

1 reference

2 August 2017

volume

8

1 reference

2 August 2017

issue

7

1 reference

2 August 2017

page(s)

819-834

1 reference

Impact of irritable bowel syndrome on personal relationships and working practices

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Systematic review: the safety and tolerability of pharmacological agents for treatment of irritable bowel syndrome--a European perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

An evidence-based position statement on the management of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Prevalence and demographics of irritable bowel syndrome: results from a large web-based survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

The effect of irritable bowel syndrome on health-related quality of life and health care expenditures

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

International survey of patients with IBS: symptom features and their severity, health status, treatments, and risk taking to achieve clinical benefit

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Food choice as a key management strategy for functional gastrointestinal symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

The functional gastrointestinal disorders and the Rome III process

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Effects of gut-directed hypnotherapy on IBS in different clinical settings-results from two randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Food: the forgotten factor in the irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Design of clinical trials evaluating dietary interventions in patients with functional gastrointestinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Diet in the irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Relationship between patterns of alcohol consumption and gastrointestinal symptoms among patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Review article: lactose intolerance in clinical practice--myths and realities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Fructose malabsorption and symptoms of irritable bowel syndrome: guidelines for effective dietary management

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized placebo-controlled evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Personal view: food for thought--western lifestyle and susceptibility to Crohn's disease. The FODMAP hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Fructan and free fructose content of common Australian vegetables and fruit

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Measurement of short-chain carbohydrates in common Australian vegetables and fruits by high-performance liquid chromatography (HPLC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Quantification of fructans, galacto-oligosacharides and other short-chain carbohydrates in processed grains and cereals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

A diet low in FODMAPs reduces symptoms of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Intestinal fructose transport and malabsorption in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Glucose transporter 8 (GLUT8) regulates enterocyte fructose transport and global mammalian fructose utilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

GLUT7: a new intestinal facilitated hexose transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Differential effects of FODMAPs (fermentable oligo-, di-, mono-saccharides and polyols) on small and large intestinal contents in healthy subjects shown by MRI

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Fructose malabsorption: how much fructose can a healthy subject tolerate?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Comparison of the prevalence of fructose and lactose malabsorption across chronic intestinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Fructose transporters GLUT5 and GLUT2 expression in adult patients with fructose intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Fructose-induced symptoms beyond malabsorption in FGID.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Benefits of breath hydrogen testing after lactulose administration in analysing carbohydrate malabsorption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Systematic review: effective management strategies for lactose intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

A worldwide correlation of lactase persistence phenotype and genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Physicochemical characteristics of commercial lactases relevant to their application in the alleviation of lactose intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

A novel acid-stable, acid-active beta-galactosidase potentially suited to the alleviation of lactose intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Beneficial effects of oral tilactase on patients with hypolactasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Dietary modulation of the human colonic microbiota: updating the concept of prebiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Carbohydrate fractions of legumes: uses in human nutrition and potential for health

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Short-chain fatty acids stimulate colonic transit via intraluminal 5-HT release in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Perceptions of flatulence from bean consumption among adults in 3 feeding studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Dietary fiber, inulin, and oligofructose: a review comparing their physiological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Extending our knowledge of fermentable, short-chain carbohydrates for managing gastrointestinal symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Short-chain carbohydrates and functional gastrointestinal disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease-a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Semiquantitative assessment of breath hydrogen testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Fructose and lactose intolerance and malabsorption testing: the relationship with symptoms in functional gastrointestinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Letter: oral fructose--breath hydrogen response, symptoms, both or neither?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Association of lactose sensitivity with inflammatory bowel disease--demonstrated by analysis of genetic polymorphism, breath gases and symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Rifaximin dose-finding study for the treatment of small intestinal bacterial overgrowth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

The concept of small intestinal bacterial overgrowth in relation to functional gastrointestinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Combined oro-caecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects oro-caecal transit, not small intestinal bacterial overgrowth in patients with IBS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Gut microbial adaptation to dietary consumption of fructose, artificial sweeteners and sugar alcohols: implications for host-microbe interactions contributing to obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Dietary fiber intake and risk of colorectal cancer: a pooled analysis of prospective cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Dietary Intake and Risk of Developing Inflammatory Bowel Disease: A Systematic Review of the Literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Pilot study on the effect of reducing dietary FODMAP intake on bowel function in patients without a colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Development and validation of a comprehensive semi-quantitative food frequency questionnaire that includes FODMAP intake and glycemic index

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

A combined nutrient and lactulose challenge test allows symptom-based clustering of patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Fructose- and sorbitol-reduced diet improves mood and gastrointestinal disturbances in fructose malabsorbers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Fructose malabsorption is associated with decreased plasma tryptophan

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Remarkable prevalence of coeliac disease in patients with irritable bowel syndrome plus fibromyalgia in comparison with those with isolated irritable bowel syndrome: a case-finding study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

A controlled trial of gluten-free diet in patients with irritable bowel syndrome-diarrhea: effects on bowel frequency and intestinal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Developmental changes and fructose absorption in children: effect on malabsorption testing and dietary management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Effect of age on fructose malabsorption in children presenting with gastrointestinal symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Regulation of the fructose transporter GLUT5 in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Absorption capacity of fructose in healthy adults. Comparison with sucrose and its constituent monosaccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

Apple juice, fructose, and chronic nonspecific diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.917956

10.1586/17474124.2014.917956

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference